2004 Competition Leads Patients 
European Pharmaceutical Review
OCTOBER 27, 2023
Benefits of The Future Clinical Trials Bill Chiefly, the Bill’s goal is to increase patient participation and overall, ensure clinical trials have the highest levels of safety while enabling greater regulatory pragmatism, the author explained. If achieved, this would boost the UK’s competitiveness as a leading international site for trials.
European Pharmaceutical Review
JUNE 24, 2022
The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. Reducing market exclusivity. Conclusions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
DECEMBER 19, 2022
1 However, as most biosimilars are developed by means of a complex biotechnological process in living organisms, this inevitably leads to differences between the biosimilar and the reference product. Marie Manley leads Sidley’s Life Sciences team in London and is a distinguished thought leader and adviser on EU and UK regulatory law.
European Pharmaceutical Review
AUGUST 23, 2022
To achieve this objective, the regulation amends Directive 2011/24/EU on the application of patients’ rights in cross?border Article 15 proved that transparent and effective assessments of new technologies were crucial to ensure fair competition between stakeholders that operate in the EU. governmental healthcare organisations.
PM360
JUNE 29, 2022
However, patient uptake hasn’t matched rising market competition. And among patients who have tried preventive medications for migraine, 39% said they no longer took them. Only about half of those living with migraine (52%) have tried acute therapy, and just 37% have investigated preventive therapy, the survey found.
PM360
SEPTEMBER 28, 2022
At Roche at the time, his job was to lead a task force which was given the objective of planning a strategy to preserve and protect the companies billion-dollar originator biologics franchises as well as build a plan which would counter the introduction and use of biosimilars. Look, competition is healthy.
CloserIQ
OCTOBER 10, 2018
They’ve worked with leading clients such as Twitter and Mercedes Benz. Kyruus is revolutionizing healthcare with its data-driven system that makes it easier for healthcare system to match patients to appropriate providers. Founded 2004. Salsify offers competitive benefits and a flexible vacation plan. Founded 2004.
Expert insights. Personalized for you.
85 
Let's personalize your content